The Uromigos

Follow The Uromigos
Share on
Copy link to clipboard

Broadcasting the latest developments in GU cancer

The Uromigos


    • Oct 23, 2025 LATEST EPISODE
    • weekdays NEW EPISODES
    • 28m AVG DURATION
    • 456 EPISODES


    Search for episodes from The Uromigos with a specific topic:

    Latest episodes from The Uromigos

    Episode 455: ESMO 2025 Urothelial Cancer Review

    Play Episode Listen Later Oct 23, 2025 27:19


    Tom and Brian discuss the bladder cancer highlights from ESMO 2025. Show throwing is discussed.

    Episode 454: ESMO 2025 Prostate and Kidney Cancer Review

    Play Episode Listen Later Oct 23, 2025 46:15


    Silke, Tom and Brian discuss the prostate and RCC highlights from ESMO 2025

    Episode 453: ESMO 2025 - IMvigor011

    Play Episode Listen Later Oct 20, 2025 37:27


    Alex Wyatt joins us to discuss Tom's IMvigor011 data and the field of ctDNA

    Episode 452: ESMO 2025 - DV+ toripalimab in bladder cancer

    Play Episode Listen Later Oct 19, 2025 42:51


    Matt Galsky discusses the exciting Presidential session data from the Chinese phase 3 of DV+ toripalimab in advanced urothelial cancer.

    Episode 451: ESMO 2025 - PSMAddition

    Play Episode Listen Later Oct 19, 2025 30:31


    Scott Tagawa discusses his ESMO Presidential presentation on Lu-PSMA-617 in patients with mHSPC

    esmo mhspc
    Episode 450: ESMO 2025 - CAPITELLO

    Play Episode Listen Later Oct 19, 2025 21:35


    Elena Castro describes the CAPITELLLO prostate cancer trial and her analysis from ESMO 2025

    Episode 449: ESMO 2025 - ENZARAD

    Play Episode Listen Later Oct 19, 2025 28:00


    Paul Nguyen and Chris Sweeney double team the ENZARAD data and put it into context with other data including STAMPEDE

    Episode 448: Neoadjuvant EV/Pembro in Cis-ineligible MIBC

    Play Episode Listen Later Oct 18, 2025 46:21


    Christof Vulsteke joins Brian and Tom to discuss his practice-changing data on neoadjuvant EVP in MIBC. More applause!!

    Episode 447: ESMO 2025 - RAMPART

    Play Episode Listen Later Oct 18, 2025 36:41


    James Larkin joins to discuss adjuvant durva/treme vs observation in high risk resected RCC

    Episode 446: ESMO 2025 - OPTIC and front-line RCC triplets

    Play Episode Listen Later Oct 18, 2025 36:20


    Cristina Rodriguez joins us to discuss her data on front-line triplets, and we also discuss the prospective RNAseq-based biomarker OPTIC study

    Episode 445: ESMO 2025 - Systemic Checkpoint Inhibition plus BCG in NMIBC (POTOMAC and ALBAN)

    Play Episode Listen Later Oct 17, 2025 36:54


    Brad McGregor joins us on the heels of his #ESMO25 discussion of these important data in the NMIBC landscape.

    Episode 444: ESMO 2025 Preview - Prostate and Renal Cancer

    Play Episode Listen Later Oct 8, 2025 41:58


    Silke joins us to discuss some important data being presented in prostate cancer. Brian and Tom also cover the RCC data at ESMO 2025

    Episode 443: ESMO 2025 Bladder Cancer Preview

    Play Episode Listen Later Oct 2, 2025 32:09


    Tom and Brian preview the practice-changing bladder cancer data to be presented at ESMO 2025 in Berlin

    Episode 441: The History of IO in Urothelial Cancer - Part 2

    Play Episode Listen Later Sep 29, 2025 33:16


    Jonathan Rosenberg returns to finish this two-part series on IO drug development in urothelial cancer

    Episode 440: The History of IO in Urothelial Cancer - Part 1

    Play Episode Listen Later Sep 22, 2025 45:39


    Jonathan Rosenberg joins in this 2-part series on the history of IO-based therapy in Urothelial Cancer

    Episode 439: Transcriptome Expression and Treatment Sensitivity in Prostate Cancer

    Play Episode Listen Later Sep 15, 2025 41:24


    Gert Attard joins the show to discuss his recent Cell publication looking at tumor transcriptome-wide expression classifiers in advanced prostate cancer.

    Episode 438: The History of Testis Cancer Treatment

    Play Episode Listen Later Sep 8, 2025 39:22


    Christian Kollmannsberger joins us to walk through decades of advances in advanced testis cancer.

    Episode 437: Uromigos Japan - バルバーサ (Erdafitinib)を実臨床でどう使うか!

    Play Episode Listen Later Sep 1, 2025 44:36


    Erdafitinibがついに承認されましたが、依然として多くのCQが残されています。日常診療に役立つ最新のデータをもとに、その活用法についてディスカッションしました。

    Episode 436: The History of IO in RCC - Part 2

    Play Episode Listen Later Aug 25, 2025 36:29


    We continue our conversation with Mike Atkins and David McDermott, discussing IO-based combination therapy in RCC.

    Episode 435: The History of IO in RCC - Part 1

    Play Episode Listen Later Aug 18, 2025 27:52


    The fathers of IO therapy in RCC - Michael Atkins and David McDermott - join us to take a tour through IO development in RCC over the last 20 years.

    Episode 434: IMPACT series - A Walk Through the History of VEGF TKI Development in RCC

    Play Episode Listen Later Aug 4, 2025 48:51


    Danny Heng joins to tour through VEGF TKI drug development from sorafenib to tivozanib and everything in between.

    Episode 433: Uromigos Japan - 改訂版ASCO mCRPCガイドライン

    Play Episode Listen Later Aug 1, 2025 39:46


    5月に改訂されたASCOのmCRPC薬物療法のガイドラインについて3人でディスカッションしました!!評価はいかに?

    Episode 432: ASCO 2025 Rapid Oral Session RCC/Bladder Recap

    Play Episode Listen Later Jul 21, 2025 27:49


    Karie Runcie, MD joins us after chairing the ASCO 2025 rapid oral session to discuss the rcc/bladder presentations.

    Episode 431: IMPACT series - Axel Bex on Impactful RCC Clinical Trials

    Play Episode Listen Later Jul 14, 2025 43:59


    Axel Bex joins the show to discuss trials that he thinks have impacted RCC. We also discuss consolidative approaches, neoadjuvant trials and what can impact an academic career.

    Episode 430: Structured Exercise Improves DFS/OS after Adjuvant Therapy in Colorectal Cancer - Does This Apply to GU Cancers?

    Play Episode Listen Later Jul 7, 2025 45:46


    Chris Booth joins the show to discuss his recent NEJM paper that demonstrated significant DFS and OS improvements with a structured exercise program after adjuvant chemo in colorectal cancer. We discuss implications for GU and other malignancies.

    Episode 429: ASCO2025レポート

    Play Episode Listen Later Jul 2, 2025 42:47


    ASCO2025の注目演題を取り上げ解説、ディスカッションしました!

    Episode 428: ASCO 2025 Recap

    Play Episode Listen Later Jun 16, 2025 54:20


    Brian, Tom and Silke discuss their highlights form ASCO 2025

    Episode 427: Emerging Data in Non-muscle Invasive Bladder Cancer (NMIBC)

    Play Episode Listen Later Jun 13, 2025 40:27


    Josh Meeks joins us to give stellar overview of the emerging data in this space. We also discuss the recent ODAC ruling for lower risk patients.

    Episode 426 - ASCO 2025: AMPLITUDE Phase 3 of PARPi in mHSPC

    Play Episode Listen Later Jun 6, 2025 37:22


    Gert Attard joins us to discuss this practice-changing data and the highlight of ASCO 2025

    Episode 425: ASCO 2025 - AI-enabled selection of patients for benefit of ADT + ARPI

    Play Episode Listen Later Jun 4, 2025 19:39


    Nick James discusses intriguing data from STAMPEDE to us AI to analyze pathology slides to predict benefit from ADT + abiraterone

    Episode 424: ASCO 2025 - Emergency podcast on the prostate rapid oral session

    Play Episode Listen Later Jun 2, 2025 30:10


    Jorge Garcia joins us to discuss the process of selecting abstracts for oral presentation and select highlights from this session.

    Episode 423: ASCO 2025 - Casdatifan plus Cabo in refractory RCC

    Play Episode Listen Later Jun 1, 2025 30:49


    Toni Choueiri discusses this combination cohort of HIF inhibition plus VEGF-R inhibition.

    Episode 422: ACSO 2025 - ctDNA data from NIAGARA

    Play Episode Listen Later Jun 1, 2025 32:40


    Matt Galsky discusses the ASCO 2025 data regarding ctDNA from the NIAGARA neoadjuvant chemo +/- durvalumab study.

    Episode 421: ASCO 2025 - Maintenance Avelumab +/- SG in Advanced Bladder Cancer

    Play Episode Listen Later Jun 1, 2025 34:49


    Jeannie Hoffman-Censits discusses her randomized phase 2 adding SG to maintenence avelumab in mUC.

    Episode 420: ASCO 2025 - CheckMate 901: Ipi/Nivo vs chemo for Cis-ineligible metastatic urothelial cancer

    Play Episode Listen Later Jun 1, 2025 24:18


    Michiel Van Der Heijden joins us to discuss the Ipi/Nivo vs chemo randomization in this trial from his ASCO 2025 presentation

    Episode 419: ASCO 2025 - Correlate data from the IMmotion 010 RCC adjuvant study

    Play Episode Listen Later May 31, 2025 23:49


    Monty Pal discusses more correlates from this trial including matched baseline and progression tissue samples.

    Episode 418: ASCO 2025 - Biomarkers in RCC

    Play Episode Listen Later May 31, 2025 44:55


    David McDermott joins us on the heels of his outstanding discussion of the clinical science symposium on RCC biomarkers.

    Episode 417: ASCO25 GUの注目演題について3人でDiscussion!!

    Play Episode Listen Later May 24, 2025 34:29


    Practice Changing?  独断と偏見で選んだ注目演題について結果の予想も含めて議論しました。

    Episode 416: ASCO 2025 Preview

    Play Episode Listen Later May 19, 2025 40:43


    Silke, Tom and Brian discuss what they are looking forward to at ASCO 2025

    Episode 415: Uromigos Score 前立腺がん編

    Play Episode Listen Later May 12, 2025 44:02


    日本と海外の違いはあるのか?mHSPCとmCRPCのUromigos Scoreについて激論!!

    Episode 414: Uromigos score en cáncer de próstata metastasico - más allá de las guías clínicas

    Play Episode Listen Later May 12, 2025 28:23


    Edición especial en castellano con Alfonso Gómez de Liaño y Guillermo de Velasco. David Lorente da su visión sobre el nuevo Uromigos Score, que clasifica distintas opciones de tratamiento en varios escenarios de cáncer de próstata metastásico

    Episode 413: The Uromigos Score for Advanced Prostate Cancer

    Play Episode Listen Later May 12, 2025 37:02


    Silke and Chris joins us to discuss our latest 'Uromigos Score' in which experts score the value of treatments for advanced prostate cancer. Several interesting themes emerge.

    Episode 410: AUA 2025 - BOND-003 Cohort C: Cretostimogene in BCG-Unresponsive NMIBC

    Play Episode Listen Later May 5, 2025 28:52


    Mark Tyson from Mayo Clinic joins the podcast to discuss this replicating adenovirus and a high CR rate in BCG-unresponsive NMIBC

    Episode 412: AUA 2025 - TAR-200 Monotherapy in BCG-Unresponsive NMUIBC from SunRISe-1

    Play Episode Listen Later May 5, 2025 37:20


    Joe Jacob joins the show to discuss the longer-term follow up of this cohort from SunRISe-1. We discuss definitions of CR and regulatory issues around drug approval in this space as well.

    Episode 411: Live from EIKCS in Amsterdam - RCC Highlights

    Play Episode Listen Later May 3, 2025 20:26


    Viktor Grunwald joins to discuss the new data session from EIKCS

    Episode 410: AUA 2025 - BOND-003 Cohort C: Crestimogene in BCG-Unresponsive NMIBC

    Play Episode Listen Later Apr 27, 2025 29:08


    Mark Tyson from Mayo Clinic joins the podcast to discuss this replicating adenovirus and a high CR rate in BCG-unresponsive NMIBC

    Episode 409: AUA 2025 - CREST - BCG +/- Sasanlimab in high-risk NMIBC

    Play Episode Listen Later Apr 26, 2025 47:27


    Neal Shore joins the show to discuss these exciting data from the American Urological Association Annual Meeting

    Episode 407: Uromigos Japan - European Delphi Study of mRCCについてdiscussion

    Play Episode Listen Later Apr 23, 2025 33:04


    今月Eur Urol OncolにPublishされたヨーロッパのエキスパートによるmRCCのコンセンサスについて日本との違いについて深い議論をしました!!

    Episode 407: Drug Development in China: Part 2 of 2

    Play Episode Listen Later Apr 21, 2025 25:21


    Part 2 of our series dives deeper into the explosion of ADC clinical drug development in China

    Episode 406: Drug Development in China: Part 1 of 2

    Play Episode Listen Later Apr 14, 2025 30:02


    Drs. Dingwei Ye and Yao Zhu from China join the show to talk about drug development in China amid the recent surge of GU clinical trials.

    Episode 405: The Good News About Cancer podcast

    Play Episode Listen Later Apr 11, 2025 17:53


    Drs. Alicia Morgans and Chuck Ryan join the show to talk about their new podcast.

    Claim The Uromigos

    In order to claim this podcast we'll send an email to with a verification link. Simply click the link and you will be able to edit tags, request a refresh, and other features to take control of your podcast page!

    Claim Cancel